Trans–NIH Workshop

Genome-wide Association: Analyze This!
The Genes, Environment, and Health Initiative

Draft Agenda

 
Monday, August 4, 2008
7:30 – 8:30 a.m. Registration
8:30 a.m.

Welcome, Opening Remarks, and Workshop Goals
Dina Paltoo, Ph.D., M.P.H.
Christopher O'Donnell, M.D., M.P.H.
National Heart, Lung, and Blood Institute

Brenda Weis, Ph.D.
National Institute on Alcohol Abuse and Alcoholism

8:45 – 10:00 a.m.

Session I: Workshop Focus

Moderator:
Christopher O'Donnell, M.D., M.P.H.
National Heart, Lung, and Blood Institute
 

State of the Science of Genome-wide Association
Teri Manolio, M.D., Ph.D.
National Human Genome Research Institute

  Environmental Exposures Measures
Patty S. Freedson, Ph.D.
University of Massachusetts at Amherst
 

Practical Translation of GWAS Findings: Interpretations and Extensions
Lon Cardon, Ph.D.
GlaxoSmithKline
10:00 – 10:30 a.m. Break
10:30 a.m. – Noon

Session II: Analysis Topics for GWAS

Moderator:
Lon Cardon, Ph.D.
GlaxoSmithKline

 

National Human Genome Research Institute Perspective
Alan E. Guttmacher, M.D.
National Human Genome Research Institute
 

The Impact of Structural Genomic Variation in Humans
Charles Lee, Ph.D., FACMG
Brigham and Women’s Hospital, Harvard Medical School
 

Gene-by-Environment Interaction Based on Family Studies
Clarice Weinberg, Ph.D.
National Institute of Environmental Health Sciences
 

Analysis of DNA Methylation Arrays
E. Andres Houseman, Sc.D.
Harvard School of Public Health

Noon – 1:00 p.m. Lunch (on your own)
   
1:00 – 2:30 p.m.

Session II: Analysis Topics for GWAS (continued)

Moderator:
Nancy J. Cox, Ph.D.
The University of Chicago
 

Population Genetics and Replication of Associations
Noah Rosenberg, Ph.D.
University of Michigan Medical School

  Multiple Phenotypes, One GWAS: Challenges, Opportunities
Christopher O'Donnell, M.D., M.P.H.
National Heart, Lung, and Blood Institute
 

On Missing Data and Genotyping Errors in Association Studies
Ingo Ruczinski, Ph.D.
Johns Hopkins University
2:30 – 3:00 p.m. Break
3:00 – 5:00 p.m. Session III: Poster Session
5:00 p.m. Adjourn
   
Tuesday, August 5, 2008
8:30 – 10:30 a.m.

Session IV: GWAS and Interactions

Moderator:
Lon Cardon, Ph.D.
GlaxoSmithKline

 

Using Ontologies in Hierarchical Modeling of Genes and Exposures in Biologic Pathways
David V. Conti, Ph.D.
University of Southern California
 

Interventions/Pharmacogenetics
Michael A. Province, Ph.D.
Washington University School of Medicine
 

Following Up GWAS With Pathway-based Analysis
Chris Amos, Ph.D.
University of Texas M.D. Anderson Cancer Center
  Consideration of G X E and Pleiotropy in GWAS for Diabetic Complications
Nancy J. Cox, Ph.D.
The University of Chicago
10:30 – 11:00 a.m. Break
11:00 a.m. – 1:00 p.m.

Session V: Future Approaches to GWAS Analyses

Moderator:
Nancy J. Cox, Ph.D.
The University of Chicago
 

Future Approaches to GWAS Analyses: FDA Perspective
Federico Goodsaid, Ph.D.
U.S. Food and Drug Administration
 

Applying New Sequencing Technology to GWAS Follow-Up
Stacey Gabriel, Ph.D.
Broad Institute of MIT and Harvard

 

What GWAS Can and Can't Do
Hakon Hakonarson, M.D., Ph.D.
The Children's Hospital of Philadelphia
 

GWAS and Other –Omics: The Need for Data Integration
Yves A. Lussier, M.D.
The University of Chicago

1:00 p.m.

Final Questions and Closing Remarks         
Thomas Lehner, M.D., M.P.H.
National Institute of Mental Health

Up to Top

This page last updated: July 28, 2008